We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » AETERNA ZENTARIS PRESENTED POSITIVE IN VIVO DATA ON ZEN-019, AN ORAL, LHRH ANTAGONIST PEPTIDOMIMETIC
AETERNA ZENTARIS PRESENTED POSITIVE IN VIVO DATA ON ZEN-019, AN ORAL, LHRH ANTAGONIST PEPTIDOMIMETIC
June 27, 2006
AEterna Zentaris Inc. today announced that it presented Abstract No. P3-257
during a poster presentation entitled "ZEN-019, A Peptidomimetic from a
New Class of Orally Active GnRH (LHRH) Antagonists," on Monday, June 26,
2006 in the Exhibit Hall of the Boston Convention & Exhibition Center in
Boston, Massachusetts, during the 2006 Annual Meeting of the Endocrine Society.
